These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21753250)

  • 21. Clinical-epidemiological trends of herpes zoster: a 5-year study.
    Brănişteanu DE; Stoleriu G; Oanţă A; Dorobăţ CM; Petrariu FD; Anchidin DM; Ciubotaru FM; Brănişteanu DC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):817-22. PubMed ID: 25341306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: four case reports and a review of infantile herpes zoster.
    Kurlan JG; Connelly BL; Lucky AW
    Arch Dermatol; 2004 Oct; 140(10):1268-72. PubMed ID: 15492192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation.
    Mawatari M; Isoda A; Miyazawa Y; Sawamura M; Matsumoto M
    Transpl Infect Dis; 2015 Aug; 17(4):544-50. PubMed ID: 26041667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of herpes zoster: role of the nurse practitioner.
    Wright WL
    J Am Acad Nurse Pract; 2003 Dec; 15(12 Suppl):10-5. PubMed ID: 15055384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella-zoster virus and urologic practice: a case-based review.
    Kasabwala K; Wise GJ
    Can J Urol; 2018 Jun; 25(3):9301-9306. PubMed ID: 29900816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes zoster and its complications in Italy: an observational survey.
    di Luzio Paparatti U; Arpinelli F; Visonà G
    J Infect; 1999 Mar; 38(2):116-20. PubMed ID: 10342652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
    Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
    Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Herpes zoster in the Czech Republic--epidemiology and clinical manifestations].
    Smetana J; Salavec M; Bostíková V; Chlíbek R; Bostík P; Hanovcová I; Vacková M; Matulková P; Splino M
    Epidemiol Mikrobiol Imunol; 2010 Aug; 59(3):138-46. PubMed ID: 20925251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes zoster: when do patients present and who gets antiviral treatment?
    Wallis KA; Hood LJ; Rao K
    J Prim Health Care; 2014 Jun; 6(2):108-13. PubMed ID: 24892127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella-zoster virus infections of the central nervous system – Prognosis, diagnostics and treatment.
    Grahn A; Studahl M
    J Infect; 2015 Sep; 71(3):281-93. PubMed ID: 26073188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral skin infections in the elderly: diagnosis and management.
    Bansal R; Tutrone WD; Weinberg JM
    Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS
    Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.
    Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G
    BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Hornberger J; Robertus K
    Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.